Updated July 2026 · 8 min read

Metformin-Associated Lactic Acidosis (MALA) for ICU Nurses 2026 — The Diabetes Pill That Poisons When the Kidneys Quit

Part of the ICU Emergencies Hub — browse every related guide in one place.

Metformin is one of the safest, most-prescribed drugs in the world — millions of people with type 2 diabetes take it every day without incident. So when an older patient on metformin arrives dehydrated from a vomiting-and-diarrhea illness, confused, breathing hard, with a blood gas showing a profound acidosis and a lactate that looks like sepsis, the diabetes pill is easy to overlook. But metformin-associated lactic acidosis is exactly this story: a benign drug that becomes dangerous the moment the kidneys can no longer clear it. For the ICU nurse, connecting the dots between the acute illness, the failing kidneys, and the home medication list is what points the team toward the treatment that actually fixes it.

Why a safe drug turns dangerous

Metformin does its everyday job by nudging the liver to make less glucose, and part of how it does that involves interfering with the mitochondrial machinery and shifting metabolism toward lactate. In a healthy person with normal kidneys, the drug is cleared steadily and lactate is handled without any trouble — hence its excellent safety record. The problem is that metformin is cleared almost entirely by the kidneys and is not metabolized. So when kidney function suddenly drops — from dehydration, sepsis, heart failure, a big surgery, or contrast dye — the drug backs up. As it accumulates, it more strongly suppresses the liver's ability to clear lactate while pushing cells to make more of it. Lactate rises on both ends of the equation, the blood turns acidic, and a person who was stable on the same dose for years is suddenly critically ill. The trigger is almost always an acute event dropping the kidneys, not the metformin dose itself.

The picture at the bedside

MALA tends to look like a sick, acidotic patient of uncertain cause, and the clues that point to metformin are in the history and the labs rather than in any single dramatic sign.

The lactate in MALA can be strikingly high — sometimes higher than what the patient's perfusion alone would explain — which is a useful hint that a metabolic poison, not just tissue hypoperfusion, is driving the acidosis. But because MALA can also coexist with sepsis, the safe posture is to treat the shock and flag the metformin, rather than assuming it is one or the other.

The nurse's role: connect the dots and support the acidosis

The first contribution is investigative: notice metformin on the home medication list of any acutely ill diabetic with a severe acidosis, and make sure the team has it. The second is meticulous support of a critically acidotic patient. Watch the acid-base trend and the lactate, monitor potassium closely (both the acidosis and the kidney injury drive it up), and track urine output as the marker of the kidney injury at the root of the problem. Support the blood pressure and perfusion with fluids and, as ordered, vasopressors, because restoring kidney perfusion is part of reversing the accumulation. Anticipate frequent blood gases and lab draws, and be ready for the possibility that the patient will need dialysis.

Why dialysis, and what supportive care covers

Because metformin is small, water-soluble, and not bound up by proteins, it is removed efficiently by renal replacement therapy — which is why dialysis is uniquely effective here in a way it is not for most drug problems. Dialysis pulls the drug out, corrects the acidosis, and manages the hyperkalemia and fluid all at once. Around that, the supportive care is what any severe high-anion-gap acidosis needs: restore circulating volume and perfusion, protect the airway if mental status is declining, correct dangerous electrolytes, and continuously reassess whether the numbers are turning. The encouraging part is that when patients survive the acute episode and their kidneys recover, MALA typically resolves without lasting harm — the mortality is front-loaded in the sickest, latest-recognized cases, which is the argument for catching it early.

Prevention: the sick-day and contrast rules

MALA is largely preventable, and nurses reinforce the prevention every day through patient teaching and safe protocols. The core message to patients is the sick-day rule: hold metformin during any acute illness that causes dehydration — vomiting, diarrhea, poor intake — because that is exactly when the kidneys are at risk. In the hospital, metformin is held around procedures using iodinated contrast and around major surgery, and it is not restarted until kidney function has been confirmed stable. Every time a nurse reinforces "stop your metformin when you're sick and can't keep fluids down, and call your provider," that is front-line MALA prevention.

The nursing bottom line

Metformin-associated lactic acidosis is what happens when a genuinely safe diabetes drug meets a sudden drop in kidney function: the drug accumulates, lactate pours out and cannot be cleared, and a stable patient becomes profoundly acidotic and shocked. Suspect it in any acutely ill diabetic on metformin with a severe high-anion-gap acidosis and a very high lactate, especially after a dehydrating illness, contrast, or surgery. Stop the drug, support the perfusion and the electrolytes, watch the acid-base and potassium closely, and prepare for the definitive fix — hemodialysis — in the severe cases. Reinforce the sick-day rule with every diabetic patient you teach, and you help keep the drug on the safe side of the line it usually stays on.

Related: Acid-base and the anion gap · AKI and renal replacement therapy · DKA vs HHS · Euglycemic DKA (SGLT2 inhibitors)

Educational content for licensed clinicians. Always follow your facility's protocol and provider orders. Not medical advice.